Page 144 - 71_02

MANUEL DOMÍNGUEZ CARMONA AN. R. ACAD. NAC. FARM.

(62) HOWARD, P. J.; MAHER, L.; PRYDE, A. Y COLS. (1992): Five year prospective
(63) study of in-cidence, clinical features and diagnosis ofachalasia in Edinburg.
(64) Gut 33: 1011-1015.
HUNTER, J. G.; TRUS, T. L.; BRANUM, G. D.; WARING, J. P. (1997): Laparoscopic
(65) Heller myotomy and funduplication for achalasia. Ann Surg 225: 655-664.
(66) IHARA, H.; KOHDA, T.; MORIMOTO, F.; TSUKAMOTO, K.; KARASAWA, T.; NAKAMURA,
(67) S.; MUKAMOTO, M.; KOZAKI, S. (2003): Sequence of the gene for Clostridium
(68) botulinum type B neurotoxin associated with infant botulism, expression of
(69) the C terminal half of heavy chain and its binding activity. Biochim Biophys
(70) Acta. 1625: 19-26.
(71) JANKOVIC, J.; ORMAN, J. (1987): Botulinum A Toxin for cranial - cervical
(72) dystonia: a double- blind, placebo - controlled study. Neurology 37: 616-623.
JARA, F. M.; TOLEDO-PEREIRA, L. H.; MAGILLIGAN, D. J. (1979): Long-term re-
(73) sults of esophagomyotomy for Acalasia of esophagus. Arch Surg 114: 935-
(74) 936.
(75) JONGENEEL, C. V.; BOUVIER, J.; BAIROCH, A. (2001): A unique signature iden-
(76) tifies a family of zinc-dependent metallopeptidases. FEBS Lett. 242: 211-
214.
JORDAN, P. H. (2001): Long-term results ofesophageal m yotomy for achala-
sia. J Am Coll Surg 193: 137-145.
JUST, I.; HOFMANN, F.; GENTH, H.; GERHARD, R. (2001): Bacterial protein toxins
inhibiting low molecular mass GTP binding proteins. Int J Med Microbiol.
291: 243-50.
KAMM, M. A.; HOYLE, C. H. V.; BURLEIGH, D. E. (1991): Hereditary internal
anal sphincter myopathy causing proctalgia fugax and constipation. Gas-
troenterology 100: 805-810.
KJELLIN, A. P.; GRANQVIST, S.; RAMEL, S.; THOR, K. B. (1999): Laparoscopic
myotomy without funduplication in patients with achalasia. Eur J Surg 165:
1162-1166.
LEVINE, M. L.; MOSKOWITZ, G. W.; DORF, D. S.; BANK, S. (1991): Pneumatic
dilatation in patients with achalasia with modified Gruntzig dilator (Levi-
ne): under direct endoscopic control. Results after 5 years. Am J Gastroen-
terology 86: 1581.
LIMMROTH, V.; MICHEL, M. C. (2000): The prevention of migraine: a critical
review with special emphasis on beta-adrenoceptor blockers. British Jour-
nal of Clinical Pharmacology 52: 237-243.
MAGNI, G.; BERTOLINI, C.; DODI, G. (1986): Douleur perianal chronique: Con-
siderations psychopathologiques characteristiques. Psicopathologie 19: 170-
174.
Mainieri-Hidalgo, J. A.; Schmitz-Gerstlauer, I.; Mainieri-Breedy, G. (2002):
Rev Mex Neuroci 3: 23325.
MARTÍ, M. J.; KULISEVSKY, J.; TOLOSA, E. (1987): Tratamiento del blefarospas-
mo dist9nico y el espasmo hemifacial con toxina botulinica Med Clin (Barc):
89: 321-323.

424